Recombinant Macaca mulatta UDP-glucuronosyltransferase 2B33 (UGT2B33)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Shipping defaults to blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. Please specify your required tag type for preferential development.
Synonyms
UGT2B33; UDP-glucuronosyltransferase 2B33; UDPGT 2B33
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
25-529
Protein Length
Full Length of Mature Protein
Species
Macaca mulatta (Rhesus macaque)
Target Names
UGT2B33
Target Protein Sequence
KVLVWAAEYSHWMNMKTILEELVQRGHEVTVLASSASILFDPNNSSALKIEVFPTSLTKT EFENIIRQQIKRWSELPKDTFWLYFSQIQEIMWRFGDISIKFCKDVVSNKKLMKKLQESR FDVVLADPIFPCSELLAELFNIPLVYSLRFTPGYVFEKHCGGFLFPPSYVPVVMSELSDQ MTFMERVKNMIYVLYFDFCFQLYDMKKWDQFYSEVLGRHTTLSEIMGKADIWLIRNSWNF QFPHPLLPNVDFIGGLLCKPAKPLPKEMEEFVQSSGENGVVVFTLGSMITNMKEERANVI ASALAQIPQKVLWRFDGNKPDTLGVNTRLYKWIPQNDLLGHPKTKAFITHGGANGIYEAI YHGVPMVGIPLFADQPDNIAHMKTRGAAVQLDFDTMSSTDLANALKTVINDPLYKENVMK LSRIQRDQPVKPLDRAVFWIEFVMRHKGAKHLRPAAHDLTWFQYHSLDVIGFLLACVATV IFIIMKCCLFCFWKFTRKGKKGKSD
Uniprot No.

Target Background

Function

UDP-glucuronosyltransferases (UGTs) are crucial enzymes in the conjugation and elimination of potentially toxic xenobiotics and endogenous compounds. This UGT2B33 isozyme exhibits glucuronidating activity on estriol but does not catalyze the glucuronidation of β-estradiol. It also conjugates 4-hydroxyestrone, androsterone, diclofenac, and hyodeoxycholic acid.

Database Links
Protein Families
UDP-glycosyltransferase family
Subcellular Location
Microsome membrane; Single-pass membrane protein. Endoplasmic reticulum membrane; Single-pass membrane protein.

Q&A

How does UGT2B33 from Macaca mulatta compare structurally and functionally to other UGT2B enzymes?

UGT2B33 from Macaca mulatta shares structural and functional similarities with other UGT2B family enzymes, but with species-specific variations. The UGT2B family in humans includes several isoforms (UGT2B4, UGT2B7, UGT2B10, UGT2B11, UGT2B15, and UGT2B17) with varying tissue expression patterns and substrate specificities.

When comparing UGT2B33 to human UGT2B enzymes, researchers should consider:

  • Sequence homology analysis between rhesus UGT2B33 and human UGT2B enzymes

  • Structural comparisons of active sites and binding domains

  • Substrate specificity profiles

  • Tissue distribution patterns

The expression patterns of UGT2B enzymes in humans show tissue-specific distribution, with some exhibiting high expression in extrahepatic tissues like tonsil, tongue, and other aerodigestive tract tissues . Research methodologies comparing UGT2B33 with human UGT2B enzymes should employ careful phylogenetic analysis and functional assays to determine evolutionary relationships and conserved metabolic functions.

What are the optimal conditions for expressing and purifying recombinant UGT2B33 from Macaca mulatta?

When designing experiments for expressing and purifying recombinant UGT2B33, researchers should consider multiple expression systems and optimization strategies:

Expression System Selection:

  • Bacterial systems (E. coli): Simple but may lack post-translational modifications

  • Yeast systems (P. pastoris): Better for eukaryotic proteins with modifications

  • Mammalian cell lines: Most physiologically relevant but more complex

  • Baculovirus-insect cell systems: Good balance between yield and modifications

Optimization Parameters:

  • Expression vector design with appropriate promoters and fusion tags

  • Induction conditions (temperature, time, inducer concentration)

  • Cell lysis methods preserving enzyme activity

  • Purification strategy (typically involving affinity chromatography)

For UGT2B33 specifically, storage conditions should include a Tris-based buffer with 50% glycerol as described in technical specifications . Purified protein should be stored at -20°C for standard use, or -80°C for extended storage. Repeated freeze-thaw cycles should be avoided to maintain enzyme activity, with working aliquots stored at 4°C for up to one week .

What experimental designs are most effective for studying tissue-specific expression of UGT2B33 in Macaca mulatta?

Based on research methodologies used for studying UGT2B enzyme expression in humans, the following experimental designs would be effective for studying UGT2B33 expression in Macaca mulatta:

Quantitative Real-Time PCR (qRT-PCR) Approach:

  • Tissue collection from multiple sites (liver, lung, aerodigestive tract, pancreas)

  • RNA isolation and quality verification (RIN > 7.0)

  • cDNA synthesis with appropriate controls

  • qRT-PCR using validated primers specific for UGT2B33

  • Normalization with experimentally validated housekeeping genes (such as MT-ATP6)

Important Considerations:

  • Standard curves should be developed to calculate PCR efficiency values

  • Efficiency correction should be applied to relative quantification values

  • Cycle threshold beyond 35 cycles should be considered below quantitation limits

  • Multiple biological replicates (n ≥ 3) should be analyzed

A randomized complete block (RCB) design would be appropriate for such studies, allowing for control of variability between individual macaques while testing the effects of different tissue types on UGT2B33 expression .

How should researchers normalize and analyze UGT2B33 expression data across different tissues?

When analyzing UGT2B33 expression data across different tissues, researchers should implement a robust normalization and statistical analysis approach:

Normalization Strategy:

  • Select appropriate reference/housekeeping genes (like MT-ATP6) validated for stability across the tissues being compared

  • Apply efficiency correction to account for different PCR amplification efficiencies between target and reference genes

  • Use the formula: RQ = (E_target)^(ΔCt_target) / (E_reference)^(ΔCt_reference)

  • Consider using multiple reference genes and geometric mean normalization for improved reliability

Statistical Analysis Framework:

  • Test data for normality using Shapiro-Wilk test

  • For normally distributed data: ANOVA followed by post-hoc tests (Tukey's HSD)

  • For non-normally distributed data: Kruskal-Wallis test followed by Dunn's test

  • Apply appropriate correlation analyses to identify potential co-regulation patterns

When examining UGT2B family enzymes in humans, researchers found strong correlations between expression levels of certain UGT2B genes in specific tissues, suggesting coordinated regulation . A similar approach could be applied to UGT2B33:

Statistical ApproachApplication to UGT2B33
Pearson/Spearman correlationIdentifying tissues with correlated UGT2B33 expression
Principal Component AnalysisRevealing patterns across multiple tissue samples
Hierarchical clusteringGrouping tissues by UGT2B33 expression profiles
ANOVA with factorial designAnalyzing effects of multiple factors on UGT2B33 expression

What approaches should be used to resolve contradictory findings in UGT2B33 functional assays?

When faced with contradictory results in UGT2B33 functional assays, researchers should implement a systematic troubleshooting and validation approach:

Methodological Validation:

  • Verify enzyme activity using multiple substrates with overlapping specificities

  • Employ different detection methods for glucuronidation products (HPLC-UV, LC-MS/MS)

  • Compare results across different experimental conditions and buffers

  • Validate findings using both recombinant enzymes and native tissue microsomes

Statistical Resolution Strategies:

  • Conduct meta-analysis if multiple studies show conflicting results

  • Implement Bayesian approaches to reconcile contradictory findings

  • Use factorial experimental designs to identify interaction effects that may explain contradictions

  • Apply sensitivity analysis to identify parameters that most strongly influence results

Documentation and Reporting:

  • Maintain detailed records of all experimental conditions

  • Report all negative and contradictory findings

  • Provide raw data alongside processed results

  • Consider pre-registration of experimental protocols

How can researchers design experiments to elucidate the role of UGT2B33 in tobacco carcinogen metabolism in Macaca mulatta models?

Building on knowledge that the UGT2B subfamily plays important roles in tobacco carcinogen metabolism , researchers can design experiments to specifically investigate UGT2B33's role:

Experimental Approaches:

  • In vitro metabolism studies:

    • Incubate recombinant UGT2B33 with known tobacco carcinogens

    • Analyze reaction kinetics (Km, Vmax) for specific substrates

    • Compare with other UGT2B enzymes to determine substrate specificity

  • Tissue-specific expression analysis:

    • Quantify UGT2B33 expression in tissues targeted by tobacco carcinogens

    • Compare expression patterns with known tobacco carcinogen distribution

    • Analyze correlation between UGT2B33 expression and tissue susceptibility to carcinogenesis

  • Knock-down/Inhibition studies:

    • Use siRNA or specific inhibitors to reduce UGT2B33 activity in cell models

    • Measure changes in tobacco carcinogen metabolism and cytotoxicity

    • Assess DNA adduct formation with and without functional UGT2B33

A split-plot experimental design would be effective for these studies, particularly when examining multiple factors (different carcinogens, tissue types, time points) while controlling for individual variation between experimental subjects .

What are the most promising approaches for studying the regulatory mechanisms controlling UGT2B33 expression?

Advanced investigation of UGT2B33 regulatory mechanisms should consider multiple levels of regulation:

Transcriptional Regulation:

  • Promoter analysis through reporter gene assays

  • Identification of transcription factor binding sites using ChIP-seq

  • DNA methylation analysis of the UGT2B33 promoter region

  • Investigation of enhancer elements using chromosome conformation capture techniques

Post-transcriptional Regulation:

  • miRNA targeting analysis and validation

  • mRNA stability assays

  • Alternative splicing investigation through RNA-seq

  • Polysome profiling to assess translational efficiency

Coordinated Regulation Analysis:
Based on findings in human UGT2B enzymes showing coordinated expression patterns , researchers should investigate potential coordinated regulation of UGT2B33 with other genes:

TissuePotential Co-regulated GenesAnalysis Method
LiverOther detoxification enzymesCorrelation analysis, network analysis
Aerodigestive tractXenobiotic receptors, inflammation mediatorsPathway analysis
PancreasMetabolic enzymesSystems biology approach

For correlation analyses, researchers should calculate Pearson or Spearman correlation coefficients between UGT2B33 and other genes of interest, considering significance at P < 0.05, similar to the approach used in human UGT2B studies .

What are the key considerations for translating UGT2B33 research from Macaca mulatta to human applications?

Translating research on Macaca mulatta UGT2B33 to human applications requires careful consideration of comparative biology and methodological approaches:

Comparative Analysis Framework:

  • Identify the human ortholog(s) of UGT2B33 through phylogenetic analysis

  • Compare substrate specificity profiles between rhesus and human enzymes

  • Analyze tissue expression patterns across species

  • Evaluate regulatory mechanisms for conservation between species

Translational Research Design:

  • Develop parallel experimental protocols applicable to both macaque and human samples

  • Validate findings in human cell lines or primary tissues when possible

  • Consider physiological and metabolic differences between species when interpreting results

  • Implement rigorous statistical approaches to account for inter-species variability

The UGT2B subfamily shows species-specific differences in expression and function, with human studies showing distinct tissue-specific expression patterns . Translational research should carefully map these differences to ensure appropriate extrapolation of findings from macaque models to human applications.

How can researchers integrate UGT2B33 functional studies with broader -omics approaches?

Integration of UGT2B33 functional studies with broader -omics approaches offers opportunities for systems-level understanding:

Multi-omics Integration Strategies:

  • Genomics: Identify genetic variants affecting UGT2B33 expression or function

  • Transcriptomics: Map co-expression networks involving UGT2B33

  • Proteomics: Characterize protein-protein interactions with UGT2B33

  • Metabolomics: Profile metabolites affected by UGT2B33 activity

  • Phenomics: Connect UGT2B33 variation to physiological outcomes

Data Integration Methods:

  • Network analysis to identify UGT2B33-centered interaction networks

  • Pathway enrichment analysis to place UGT2B33 in biological context

  • Machine learning approaches to predict UGT2B33 substrates and functions

  • Multi-omics data fusion techniques to synthesize evidence across platforms

The integration of multiple data types requires rigorous experimental design, considering factors such as randomized block designs for controlling confounding variables and factorial designs for examining interaction effects . These approaches will enable a comprehensive understanding of UGT2B33's role in the broader biological context of Macaca mulatta and its potential relevance to human health and disease.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.